What growth factor would you use with A+AVD, if any at all?
3
1 Answers
Mednet Member
Medical Oncology · University of British Columbia Faculty of Medicine
When treating patients with Hodgkin lymphoma with either ABVD or A-AVD I decide if their risk of febrile neutropenia is likely to be more than 20%, which, therefore, includes some patients on ABVD and most patients on A-AVD. For such patients I give GCSF (filgrastim, grastophil) on days 6-11 after e...